Hasty Briefsbeta

Bilingual

Programmed cell death network in cancer drug resistance: A framework for therapeutic intervention - PubMed

4 days ago
  • #Cancer
  • #Programmed Cell Death
  • #Drug Resistance
  • Cancer drug resistance is a major challenge in treatment, often due to evasion of programmed cell death (PCD).
  • Six PCD modalities are discussed: apoptosis, necroptosis, pyroptosis, autophagy, ferroptosis, and cuproptosis.
  • PANoptosis links apoptosis, necroptosis, and pyroptosis; ferroptosis and cuproptosis share redox circuitry.
  • Immunogenic cell death interacts bidirectionally with the tumor microenvironment.
  • Single-agent interventions are often insufficient; synergistic, multitarget strategies are proposed.
  • Emerging tools include single-cell omics, AI modeling, CRISPR screening, and nanoparticle delivery.
  • Future research should focus on holistic PCD views, biomarkers, and combination therapies to overcome resistance.